Physician profile
Torsten P Vahl
NPI 1134379787
$280,137.78
in general payments reported to CMS, 2019-2025
18 companies · $27K in 2025
The $27K reported for 2025 was more than what 94% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53K · 2020: $17K · 2021: $10K · 2022: $9,535 · 2023: $91K · 2024: $73K · 2025: $27K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $143K · Travel and Lodging: $43K · Food and Beverage: $4,691.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $142,711.01 |
| Travel and Lodging | $43,239.38 |
| Food and Beverage | $4,691.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $175,205.77 | 2019-2025 | Lingo, Mitraclip, Xience V |
| Jenavalve Technology, INC. | $39,286.40 | 2019-2024 | Jenavalve Pericardial Tavr System |
| Philips North America LLC | $35,715.29 | 2022-2024 | (9520) Igt Devices Undivided |
| Baylis Medical Company INC | $11,850.86 | 2019-2020 | |
| Boston Scientific Corporation | $8,723.81 | 2019-2025 | Watchman Flx, Watchman Access System, Versacross Access Solution |
| Edwards Lifesciences Corporation | $5,330.39 | 2019-2025 | Sapien 3 Ultra Resilia, Pascal |
| Siemens Medical Solutions USA, INC. | $1,750.00 | 2019 | |
| Medtronic, INC. | $1,163.50 | 2021-2025 | Corevalve Evolut R, Onyx Frontier |
| Opsens INC. | $500.00 | 2019 | |
| Medtronic Vascular, INC. | $355.88 | 2020 | |
| Cardiva Medical, INC. | $77.90 | 2024 | Savvywire |
| Heartflow, INC. | $41.00 | 2025 | |
| Acist Medical Systems, INC. | $33.87 | 2025 | |
| Novartis Pharmaceuticals Corporation | $23.99 | 2024 | |
| Abiomed | $22.80 | 2023 | Impella |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $20.23 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $19.46 | 2024 | Arcalyst |
| Chiesi USA, INC. | $16.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Torsten Vahl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.